Cover Image
市場調查報告書

醫用生物成像試劑的全球市場

Biologic and Medical Imaging Reagents: Global Markets

出版商 BCC Research 商品編碼 106150
出版日期 內容資訊 英文 286 Pages
訂單完成後即時交付
價格
Back to Top
醫用生物成像試劑的全球市場 Biologic and Medical Imaging Reagents: Global Markets
出版日期: 2017年10月05日 內容資訊: 英文 286 Pages
簡介

2016年,全球生物成像試劑的市場記錄了132億美元的規模。從2017年到2022年預計以10.6%的年複合成長率發展,從2017年的144億美元,成長到2022年的239億美元的規模。

本報告提供全球醫用生物成像試劑的市場調查,全球市場概要,市場潛在性和產業的成長推動因素分析,主要技術類型和概要,試劑的各種用途,各模式、技術、終端用戶的市場規模的變化與預測,產業結構,競爭環境,以及主要企業的簡介等彙整。

第1章 簡介

第2章 摘要整理

第3章 概要

  • 簡介
  • 市場潛在性
  • 產業的成長推動因素

第4章 生物成像技術

  • 成像試劑的各種類型
  • 體內成像的模式
  • 體內成像趨勢
    • 分子影像
    • 體外成像/檢測
  • 生物成像試劑技術
    • 奈米粒子
    • 螢光色素、探針
    • 超分子
    • 量子點
    • 放射性醫藥品成像試劑
    • 造影試劑
  • 成像試劑的新興級類
    • 先進技術的零組件
    • 先進功能
  • 成像試劑技術平台比較

第5章 生物成像試劑的各種用途

  • 概要
    • R&D
    • 藥物研發、藥物開發
    • 診斷

第6章 生物成像試劑的產業結構

  • 概要
  • R&D
  • 藥物研發、藥物開發
    • 成像技術對藥物開發的影響
    • 先導藥物的損耗率
    • 開發藥劑中螢光蛋白質的用途
    • 體內小動物成像用途
  • 診斷
    • 簡介
    • 成像試劑的診斷要素
    • 分子影像

第7章 競爭環境

  • 革新
  • 策略性聯盟
  • 收購趨勢

第8章 生物成像試劑市場

  • 成長推動因素
    • 市場概要

第9章 專利情形

第10章 企業簡介

關於BCC Research

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HLC040E

The global market for biological imaging reagents was valued at $13.2 billion in 2016. This market will grow from $14.4 billion in 2017 to nearly $23.9 billion by 2022 with a compound annual growth rate (CAGR) of 10.6% for the period of 2017-2022.

Report Includes

  • An overview of the global markets for biologic and medical imaging reagents
  • Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • A comprehensive analysis of imaging techniques as an important tool in medical diagnostic procedures
  • Coverage of current and future strategies within the medical imaging technology market
  • A look at classifications, comparisons, advantages, and disadvantages of these types of diagnostic methods
  • A detailed analysis of the industry structure
  • Profiles of major players in the industry

Report Scope

Topics covered in this report include:

  • Fluorescent dyes and probes.
  • Fluorescent proteins.
  • Nanoparticles, including quantum dots.
  • Supermolecules.
  • Imaging radiopharmaceuticals.
  • Contrast reagents for X-ray/CT, MRI and ultrasound.

Topics not covered in this report include:

  • Nanotechnology.
  • Drug delivery.
  • Coatings.
  • Supramolecular chemistry.
  • Imaging instruments and software.

The scope of the study includes the biological imaging reagents that are already commercialized or likely to be commercialized within the next five years. Fluorescent probes and dyes; imaging nanomaterials (including quantum dots and other nanoparticles); fluorescent proteins; contrast reagents for MRI, X-ray and ultrasound; and imaging radiopharmaceuticals are studied. Both the in vivo and in vitro market segments are included. Each technology is analyzed to determine its market status, impact on future market segments and forecast growth from 2017 through 2022. Technology status and market driving forces are also discussed.

BCC Research examines imaging reagent producers and the industry structure in specialized segments of the industry. We also review industry alliances and acquisitions, and the use of biological imaging reagents in key diagnostics and research and development (R&D) tools platforms, including microarrays, lab-on-a-chip devices, DNA sequencing, PCR and cellular analysis. The markets for novel biological imaging reagent applications, including targeted multifunctional and hybrid therapeutic reagents, are analyzed, and the main companies in these fields are highlighted.

Analyst Credentials

Bhavna Joshi has more than six years of domain experience. In addition to business research and consulting, she has conducted corporate briefings for top players in a wide range of market segments. She holds an MBA in the marketing and finance from Chennai University and has worked with major market research firms.

Bhavna Joshi has authored several market research studies on subjects in the healthcare domain, including:

  • Healthcare tracking technologies.
  • Molecular diagnostics market.
  • High-growth markets in healthcare and life sciences.
  • Adoption rates and analysis of over-the-counter (OTC) diabetic medicines and supplements.
  • Radio frequency identification (RFID), real-time locating systems (RTLS), internet protocol (IP) surveillance and other emerging technologies in the healthcare domain.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing the Study
  • Contribution of the Study and for Whom
  • Scope of Report
  • Methodology
  • Information Sources
  • Analyst's Credentials
  • Related BCC Reports

Chapter 2: Executive Summary

Chapter 3: Overview

  • Introduction
  • Market Potential
  • Industry Growth Driving Forces
  • Industry Growth Drivers
    • Demand for Theranostics Regime
    • Image-Based Invasive and Noninvasive Procedures
    • Increasing Prevalence of Chronic Diseases and Rising Investments
    • Drug Discovery and Other R&D Activities
    • Development of Multifunctional Reagent Capabilities
    • Replacement of Toxic, Hazardous Detection Reagents with Safer Reagents
    • Biological Imaging Reagents Industry

Chapter 4: Biological Imaging Technologies

  • Imaging Reagent Types
  • In Vivo Imaging Modalities
  • Trends in In Vivo Imaging
    • Molecular Imaging
    • In Vitro Imaging/Detection
  • Biological Imaging Reagents Technologies
    • Nanoparticles
    • Fluorescent Dyes and Probes
    • Supermolecules
    • Quantum Dots
    • Radiopharmaceutical Imaging Reagents
    • Contrast Imaging Reagents
  • Emerging Classes of Imaging Reagents
    • Components of Advanced Imaging Reagent Technology
    • Advanced Imaging Reagent Functions
  • Comparison of Imaging Reagent Technology Platforms

Chapter 5: Biological Imaging Reagents Applications

  • Overview
    • Research and Development
    • Drug Discovery and Development
    • Diagnostics

Chapter 6: Biological Imaging Reagents Industry Structure

  • Overview
  • Research and Development
  • Drug Discovery and Development
    • Influence of Imaging Technology on Drug Development
    • Attrition Rate of Lead Drug Compounds
    • Fluorescent Protein Applications in Drug Discovery
    • In Vivo Small Animal Imaging Applications
  • Diagnostics
    • Introduction
    • Diagnostic Applications of Imaging Reagents
    • Molecular Imaging

Chapter 7: Competitive Landscape

  • Innovation Within the Imaging Reagent Industry
  • Strategic Alliances
  • Industry Acquisitions
    • Medical Imaging Instrument Sector
    • Fluorescent Dyes and Probes Industry Structure
    • Quantum Dots Industry
    • Contrast Reagents Industry
    • Radiopharmaceuticals Industry
    • Radioactive Isotopes Supply
    • Small Animal In Vivo Imaging Industry
    • Cardiac Imaging Industry
    • Radiopharmaceuticals for the Screening Market Segment Include Ablavar and Vasopet
    • Prostate Cancer Imaging Industry
    • Alzheimer's Disease PET Imaging Industry

Chapter 8: Biological Imaging Reagents Markets

  • Growth Driving Forces
    • Market Overview

Chapter 9: Patent Status

Chapter 10: Company Profiles

About BCC Research

  • About BCC Research
  • BCC Membership
  • BCC Custom Research

List of Tables

  • Summary Table Global Biological Imaging Reagents Market, by Modality, Through 2022 ($ Millions)
  • Table 1 Global Biological Imaging Reagents Market, by Technology, Through 2022 ($ Millions)
  • Table 2 Global Biological Imaging Reagents Market, by End User, Through 2022 ($ Millions)
  • Table 3 Biological Imaging Reagents Growth Driving Forces
  • Table 4 Current and Future Invasive and Noninvasive Imaging Technologies
  • Table 5 Other Driving Factors
  • Table 6 Life Cycle Stage of Biological Imaging Reagents.
  • Table 7 Key Biological Imaging Reagents Companies
  • Table 8 Key Biological Imaging Reagent Types
  • Table 9 In Vivo Imaging Modalities
  • Table 10 Comparison of In Vivo Imaging Modalities
  • Table 11 Key Technology Drivers for In Vivo Imaging Reagents
  • Table 12 Applications of In Vitro Biological Imaging
  • Table 13 Nanoparticles in Imaging Applications
  • Table 14 Fluorescent Dyes and Probes
  • Table 15 General Advantages of Fluorescence Labels
  • Table 16 Fluorescent Dye Performance Criteria
  • Table 17 Types of Fluorescent Proteins
  • Table 18 Photoactivable and Photoconvertible Fluorescent Protein Types
  • Table 19 Emerging Applications of Fluorescent Proteins
  • Table 20 Fluorescent Proteins Versus Dyes
  • Table 21 Technology Challenges for Fluorescent Proteins
  • Table 22 Classification of Imaging Supermolecules
  • Table 23 Comparison of Quantum Dots, Fluorescent Dyes and Fluorescent Proteins
  • Table 24 Biological Imaging Applications of Quantum Dots
  • Table 25 Microbubble Ultrasound Imaging Agents
  • Table 26 Emerging Advanced Biological Imaging Reagent Functions
  • Table 27 Life Cycle of Biological Imaging Reagent Technologies
  • Table 28 Technology Status of Biological Imaging Reagent Platforms
  • Table 29 Technology Challenges for In Vivo Imaging Reagents
  • Table 30 Biological Imaging Reagents Applications
  • Table 31 Significance of Biological Imaging Reagents to Life Sciences and Medical Industries
  • Table 32 Use of Biological Imaging Reagents, by Market Segment
  • Table 33 Applications Within Market Segments
  • Table 34 R&D Tools Imaging Reagents
  • Table 35 Emerging Applications for Biological Imaging Reagents in R&D Tools
  • Table 36 Imaging Applications in Drug Discovery and Development
  • Table 37 Comparison of Small Animal Imaging Modalities
  • Table 38 Outstanding Market Needs for Small Animal Imaging
  • Table 39 Diagnostics Imaging Reagents Applications
  • Table 40 Diagnostic Applications of Selected Imaging Reagents
  • Table 41 Clinical Applications of In Vivo Molecular Imaging
  • Table 42 Biological Imaging Reagents Applications
  • Table 43 Significance of Biological Imaging Reagents to the Life Sciences and Medical Industries
  • Table 44 Use of Biological Imaging Reagents, by Market Segment
  • Table 45 Applications Within Market Segments
  • Table 46 R&D Tools Imaging Reagents
  • Table 47 Emerging Applications for Biological Imaging Reagents in R&D Tools
  • Table 48 Imaging Applications in Drug Discovery and Development
  • Table 49 Comparison of Small Animal Imaging Modalities
  • Table 50 Outstanding Market Needs for Small Animal Imaging
  • Table 51 Diagnostics Imaging Reagents Applications
  • Table 52 Diagnostic Applications of Selected Imaging Reagents
  • Table 53 Clinical Applications for In Vivo Molecular Imaging
  • Table 54 Recent FDA Approvals in the Biological Imaging Reagent Industry
  • Table 55 Biological Imaging Reagent Strategic Alliances, 2010-2017*
  • Table 56 Biological Imaging Reagents Industry Acquisitions, 2010-2017*
  • Table 57 Competitive Focus of Major Medical Imaging Companies
  • Table 58 Fluorescent Imaging Reagents Competitors
  • Table 59 Quantum Dot Competitors
  • Table 60 Contrast Agents Key Competitors
  • Table 61 Global Imaging Radiopharmaceuticals Companies
  • Table 62 Radiopharmaceuticals Biotechnology Companies
  • Table 63 Small Animals In Vivo Functional Imaging Reagent Competitors
  • Table 64 Cardiac Imaging Reagent Competitive Space
  • Table 65 Prostate Cancer Imaging Agent Competition
  • Table 66 Alzheimer's Disease PET Imaging Agent Competitive Space
  • Table 67 Biological Imaging Reagents Growth Driving Forces
  • Table 68 Global Biological Imaging Reagents Market, by Application, Through 2022 ($ Millions)
  • Table 69 Global Biological Imaging Reagents Market, by Technology, Through 2022 ($ Million)
  • Table 70 Global Biological Imaging Reagents Market, by End Use, Through 2022 ($ Millions)
  • Table 71 Global Biological Imaging Reagents Market, by End User, Through 2022 ($ Millions)
  • Table 72 Global Biological Reagents Market, by Modality, Through 2022 ($ Millions)
  • Table 73 Global Contrast Reagents Market, by Modality, Through 2022 ($ Millions)
  • Table 74 Global MRI Contrast Reagents Market, by Type, Through 2022 ($ Millions)
  • Table 75 Global Gd-Chelate MRI Contrast Reagents Market, by Product, Through 2022 ($ Millions)
  • Table 76 Key Brands of Gadolinium-Based Contrast Reagents Worldwide
  • Table 77 Global Non-Gd Chelate MRI Contrast Reagents Market, Through 2022 ($ Millions)
  • Table 78 Global MRI Contrast Reagents Market, by Procedure, Through 2022 ($ Millions).
  • Table 79 Global X-Ray/CT Reagents Market, by Type, Through 2022 ($ Millions)
  • Table 80 Global X-Ray/CT Reagents Market, by Indication, Through 2022 ($ Millions)
  • Table 81 Global Radiopharmaceuticals Imaging Reagents Market, by Scanner Type, Through 2022 ($ Millions)
  • Table 82 Global Radiopharmaceuticals Imaging Reagents Market, by Isotope, Through 2022 ($ Millions)
  • Table 83 Global Radiopharmaceuticals Imaging Reagents Market, by Indication, Through 2022 ($ Millions)
  • Table 84 Global Radiopharmaceuticals Imaging Reagents Market, by Technology, Through 2022 ($ Millions)
  • Table 85 Global SPECT Imaging Reagents Market, by Isotope, Through 2022 ($ Millions)
  • Table 86 Half-Life of Common PET and SPECT Isotopes
  • Table 87 Sentinel Node Detection Radiopharmaceuticals Producers
  • Table 88 Global SPECT Imaging Reagents Market, by Technology, Through 2022 ($ Millions)
  • Table 89 Global PET Imaging Reagents Market, by Isotope, Through 2022 ($ Millions)
  • Table 90 Global PET Imaging Reagents Market, by Indication, Through 2022 ($ Millions)
  • Table 91 Global PET Imaging Reagents Market, by Technology, Through 2022 ($ Millions)
  • Table 92 Global Optical Fluorescent Imaging Reagents Market, by Application, Through 2022 ($ Millions)
  • Table 93 Global In Vitro Optical Fluorescent Imaging Reagents Market, by Assay Type, Through 2022 ($ Millions)
  • Table 94 Global Genomics In Vitro Optical Fluorescent Imaging Reagents Market, by Assay Type, Through 2022 ($ Millions)
  • Table 95 Global Proteomics In Vitro Optical Fluorescent Imaging Reagents Market, by Assay Type, Through 2022 ($ Millions)
  • Table 96 Global Cellular Analysis In Vitro Optical Fluorescent Imaging Reagents Market, by Assay Type, Through 2022 ($ Millions)
  • Table 97 Global Optical Fluorescent Imaging Reagents Market, by End Use, Through 2022 ($ Millions)
  • Table 98 Global In Vitro Optical Imaging Reagents Market, by Type, Through 2022 ($ Millions)
  • Table 99 Global Biological Imaging Reagents Market, by Region, Through 2022 ($ Millions)
  • Table 100 U.S. Patents on Imaging Reagents Through 2017
  • Table 101 European Patents on Imaging Reagents, Through 2017
  • Table 102 Japanese Patents on Imaging Reagents, Through 2017
  • Table 103 Affibody Alliances
  • Table 104 FluoroPharma PET Imaging Reagent Pipeline
  • Table 105 Kereos Imaging Reagents Pipeline
  • Table 106 Molecular Insight Imaging Reagents Pipeline
  • Table 107 Lymph Node Status

List of Figures

  • Summary Figure Global Biological Imaging Reagents Market, by Modality, 2016-2022 ($ Millions)
  • Figure 1 Factors Impacting the Growth of the Biological Imaging Reagents Market, 2016 and 2023
  • Figure 2 Current and Forecast Venture Capitalist Investment in the U.Sand European Medical Device Sectors, 2014-2018 ($ Billions)
  • Figure 3 Forecast Investment in Drug Development and Research Spending, by Pharmaceutical Company, 2014-2020 ($ Billions)
  • Figure 4 Quantum Dot Spectra (Intensity) (Arb units, nm)
  • Figure 5 Fluorescent Dye Spectra (Arb units, nm)
  • Figure 6 Three Components of Advanced Imaging Reagent Technology
  • Figure 7 Attrition Rate of Drug Candidates During Drug Development
  • Figure 8 Global Geriatric Population (65+), 2015 and 2020 (Millions)
  • Figure 9 Global R&D Spending in Nanotechnology, 2013-2015 ($ Billions)
  • Figure 10 Worldwide Prevalence of Alzheimer's, 2015, 2030 and 2050 (Millions)
  • Figure 11 Number of New Cancer Cases Found in North America by Country, 2016
  • Figure 12 Number of People Impacted by Disability Adjusted Life Year Due to Alzheimer's Disease, 2005- 2030 (Thousands)
Back to Top